
Cognyte Software Ltd. CGNT
$ 8.48
0.71%
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
72.9 M |
Market Cap[1] |
$ 618 M |
EBITDA (LTM) |
$ -55.7 M |
P/E (LTM) |
-5.0 |
P/S (LTM) |
0.55 |
EPS (LTM) |
-2.08 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Inogen
INGN
|
$ 5.45 | 1.11 % | $ 145 M | Nasdaq Global Select Market,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 125.5 | 0.15 % | $ 4.36 B | NYSE,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 22.59 | 1.17 % | $ 530 M | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
LivaNova PLC
LIVN
|
$ 81.2 | 2.79 % | $ 4.43 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 8.25 | 0.06 % | $ 98.7 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 14.05 | 0.67 % | $ 398 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Myomo
MYO
|
$ 1.4 | 1.42 % | $ 58.6 M | NYSE American | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Nano-X Imaging Ltd.
NNOX
|
$ 0.71 | 1.3 % | $ 46 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
PAVmed
PAVM
|
$ 5.09 | 0.19 % | $ 3.41 M | Nasdaq Capital Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Insulet Corporation
PODD
|
$ 150.58 | 1.65 % | $ 10.6 B | Nasdaq Global Select Market,SPB | ||
|
Quanterix Corporation
QTRX
|
$ 2.58 | 3.98 % | $ 110 M | Nasdaq Global Select Market,SPB | ||
|
AVITA Medical
RCEL
|
$ 10.94 | 1.67 % | $ 305 M | Nasdaq Global Select Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.35 | 0.94 % | $ 21.8 M | Nasdaq Capital Market | ||
|
Sintx Technologies
SINT
|
$ 1.54 | 1.32 % | $ 4.27 M | Nasdaq Capital Market | ||
|
SmileDirectClub
SDC
|
- | -53.45 % | $ 9.71 M | Nasdaq Global Select Market | ||
|
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | Nasdaq Global Select Market | ||
|
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.